Ex Parte Draudt et alDownload PDFPatent Trial and Appeal BoardDec 21, 201613330330 (P.T.A.B. Dec. 21, 2016) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/330,330 12/19/2011 Gregg R. Draudt P6267C1C1 (66810-469) 6677 47058 7590 12/23/2016 David W. Highet, VP & Chief IP Counsel Becton, Dickinson and Company (Dickinson Wright PLLC) 1 Becton Drive, MC 110 Franklin Lakes, NJ 07417-1880 EXAMINER HOEKSTRA, JEFFREY GERBEN ART UNIT PAPER NUMBER 3736 NOTIFICATION DATE DELIVERY MODE 12/23/2016 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): lorraine_kow alchuk @ bd .com ip_docket @bd.com DWPatents @ dickinson wright. com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte GREGG R. DRAUDT, DIRK AHLGRIM, JAN SCHMINKE, MARK FOLLMAN, JOSE COLUCCI, JR., RAYMOND YAO, ROBERT J. MCCAFFREY, AND VICTOR CHAN Appeal 2014-0066271 Application 13/330,3302 Technology Center 3700 Before MICHAEL C. ASTORINO, KEVIN W. CHERRY, MATTHEW S. MEYERS, Administrative Patent Judges. CHERRY, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Gregg R. Draudt et al. (Appellants) seek review under 35U.S.C. § 134 of a Final Rejection of claims 1—13, the only claims pending in the application on appeal. We have jurisdiction over the appeal 1 Our decision references the Appellants’ Appeal Brief (“Appeal Br.”), filed December 17, 2013, Appellants’ Reply Brief (“Reply Br.”), filed May 19, 2014, the Examiner’s Final Action (“Final Act.”), mailed July 19, 2013, and the Examiner’s Answer (“Ans.”), mailed March 18, 2014. 2 Appellants’ Appeal Brief identifies “Becton, Dickinson and Company,” as the real party in interest for this appeal (Appeal Br. 4). Appeal 2014-006627 Application 13/330,330 pursuant to 35 U.S.C. § 6(b). Appellants failed to appear for the oral hearing scheduled for November 4, 2016. We REVERSE. Appellants’ claimed invention relates to “a blood glucose meter with an integral lancet device, and a location on the device to store test strip vials such that one-handed use for lancet device, meter and test strip access functions are possible” (Spec. 12). Claims 1 and 10-13 are independent. Claim 1 is a device claim and claims 10—13 are method claims. Claims 1 and 10 are illustrative of the subject matter on appeal and are reproduced below (with paragraphing added). 1. A blood glucose meter device for single handed use, comprising: a body having first and second ends; a lancet device disposed at said first end of said body, said lancet device comprising a trigger button disposed on said body for activating said lancet device, an arming slide disposed on said body for arming said lancet device, a cylindrical depth control mechanism for setting a lancet skin penetration depth and for engaging a skin surface, and a surface for supporting said skin surface when rolled toward an adjacent test strip; a test strip port disposed at said first end of said body for positioning a test strip substantially parallel and adjacent to said lancet device; and an enclosure for housing a test strip vial disposed at said second end of said body. (Appeal Br. 35, Claims App.). 10. A method of facilitating one-handed use of a blood glucose meter device, comprising: 2 Appeal 2014-006627 Application 13/330,330 providing a test strip port adjacent to a lancet mechanism; transferring a test strip from a test strip vial contained in said device to said test strip port such that said test strip is located substantially parallel and adjacent to said lancet mechanism; activating said lancet mechanism against a skin surface to provide a blood drop; and transferring said blood drop from said skin surface to said adjacent test strip by resting said skin surface upon said lancet mechanism and rolling said skin surface toward said test strip in a substantially continuous motion to move said blood drop to said adjacent test strip. (Appeal Br. 36—37, Claims App.). Rejections Claims 1—13 stand rejected under 35 U.S.C. § 112, second paragraph, as being unpatentable, as being indefinite for failing to particularly point out and distinctly claim the subject matter the applicant regards as the invention. ANALYSIS “Substantially parallel ” Claim 1 recites “a test strip port disposed at said first end of said body for positioning a test strip substantially parallel and adjacent to said lancet device” (Appeal Br. 35, Claims App.). Claims 10-13 similarly require that “said test strip is located substantially parallel and adjacent to a lancet mechanism” {id. at 36—38, Claims App.). In the Final Action, the Examiner based the rejection on the use of the term “substantially” because the term was not defined by the claims, the Specification does not provide a standard for ascertaining the requisite degree of the term, and one of ordinary skill 3 Appeal 2014-006627 Application 13/330,330 would not be reasonably apprised of the scope of the invention (Final Act. 2). In the Answer, the Examiner submitted that there was no ordinary meaning of the term “substantially parallel,” and no standard definition of the term (Ans. 3, 4). In addition, the Examiner noted that “substantially parallel” is unclear because neither the figures nor the claims have sufficient detail to provide a definition for the term {id. at 3 4). Finally, the Examiner notes that the meaning of “parallel” is “equidistant,” so something is either parallel or it is not parallel and there is no such thing as “substantially parallel” {id. at 4). Appellants argue, and we agree, that the term “substantially parallel” does not render the claims indefinite (Appeal Br. 4; see also Reply Br. 2—8). Although the Specification does not expressly recite “substantially parallel,” Figures 3—11 depict test strip 76 disposed in a position that is essentially parallel with lancet device 30 {see Spec., Figs. 3—11). In light of these Figures, one of ordinary skill in the art would readily understand the claim language “substantially parallel,” in light of the ordinary meaning of “substantially” and when read in the context of the Specification, to mean that the test strip is largely but not wholly parallel with the lancet.3 See, e.g., Anchor Wall Sys., Inc. v. RockwoodRetaining Walls, Inc., 340 F.3d 1298 (Fed. Cir. 2003) (Finding the term “generally parallel” definite noting that the term “envision[s] some amount of deviation from exactly parallel.”); Ecolab, Inc. v. Envirochem, Inc., 264 F.3d 1358, 1367 (Fed. Cir. 2001) (noting that terms such as “substantially” are used ubiquitously in patent 3 An ordinary meaning of “substantially” is “being largely but not wholly that which is specified.” See www.merriam-webster.com/dictionary/substantially, last visited on Dec. 20, 2016. 4 Appeal 2014-006627 Application 13/330,330 claims to avoid a strict numerical boundary to the specified parameter without necessarily rendering the claims indefinite). As such, the claim language defines the claimed subject matter with an adequate degree of particularity and distinctness such that one of ordinary skill in the art would understand what is being claimed as to the position of the test strip relative to the lancet as called for in claims 1 and 10—13 (and in claims 2—9 that depend from claim 1). “Substantially continuous motion ” Claims 10—13 also recite that the step of transferring or applying the blood drop on the user’s skin surface to the test strip occurs using “a substantially continuous motion” (Appeal Br. 37—39, Claims App.). The Examiner raised a similar faults, as we considered above with respect to “substantially parallel,” regarding the use of the word “substantially” in “substantially continuous” (Final Act. 2; see also Ans. 6—7). The Examiner submitted that there was uncertainty in the amount of non-continuous motion permissible (Final Act. 2; see also Ans. 6—7). The Examiner further submitted that the Specification, figures, and claims do not provide any teaching of a standard of measuring the relative term of degree “substantially” in any instance of the claimed subject matter, and therefore the relative term of degree of “substantially” renders claims 10—13 indefinite (Ans. 6—7). We agree with Appellants that the term “substantially continuous motion” recited in claims 10-13 is not indefinite (Appeal Br. 16—33; see also Reply Br. 12—13). The Specification uses the term and describes in detail the method of using the glucose meter (see Spec. 39, 40, 42). In light of this explanation, one of ordinary skill in the art would readily understand the 5 Appeal 2014-006627 Application 13/330,330 claim language “substantially continuous motion,” in light of the ordinary meaning of “substantially,” discussed above, and when read in the context of the Specification, to mean that the motion is mostly, but not exactly continuous. As such, the claim language defines the claimed subject matter with an adequate degree of particularity and distinctness such that one of ordinary skill in the art would understand what is being claimed as to the type of motion called for in claims 10—13. Summary Accordingly, we reverse the rejection of claims 1—13 under 35 U.S.C. §112, second paragraph, as being indefinite. DECISION The Examiner’s decision to reject claims 1—13 is reversed. REVERSED 6 Copy with citationCopy as parenthetical citation